Annie Kannarkatt
Hematology & Oncology · York, PANPI 1750380036
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,029 of the $1,171 with a category attached, or 87.9%. It is spread thinly across 30 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $381 and has fallen 59.8% since, to $153 in 2022. That places this record below the midpoint for hematology & oncology clinicians in PA, where the typical reported total is $1,277.
Across 80 payments — averaging $14.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$273
- Sun Pharmaceutical Industries Inc.$86
- Astellas Pharma US Inc$85
- Bayer$74
- E.r. Squibb & Sons, L.L.C.$71
- AbbVie$64
- plus $519 from 24 others
What the payments were for
- Food & beverage$1,02988%
- Education$14212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 26 | $273 |
| Sun Pharmaceutical Industries Inc. | 1 | $86 |
| Astellas Pharma US Inc | 1 | $85 |
| Bayer | 5 | $74 |
| E.r. Squibb & Sons, L.L.C. | 5 | $71 |
| AbbVie | 5 | $64 |
| Global Blood Therapeutics, Inc. | 3 | $44 |
| Karyopharm Therapeutics Inc. | 3 | $41 |
| Janssen Scientific Affairs, LLC | 3 | $41 |
| AstraZeneca | 3 | $39 |
| Lexicon Pharmaceuticals, Inc. | 2 | $36 |
| Beigene USA, Inc. | 2 | $28 |
| Daiichi Sankyo Inc. | 2 | $25 |
| EMD Serono, Inc. | 2 | $24 |
| GSK | 1 | $23 |
| Genentech USA, Inc. | 2 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Bristol Myers Squibb | 1 | $20 |
| Stemline Therapeutics Inc. | 1 | $20 |
| Octapharma USA, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $13 |
| EUSA Pharma (US) LLC | 1 | $12 |
| Sanofi | 1 | $12 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Gilead | 1 | $12 |
| Acrotech Biopharma Inc. | 1 | $12 |
| AVEO Pharmaceuticals, Inc. | 1 | $12 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $12 |
| Seagen Inc. | 1 | $11 |
| Aurobindo Pharma USA, Inc. | 1 | $11 |
How this compares
$1,171 in reported general payments places this provider in the 45th percentile of 682 hematology & oncology providers in Pennsylvania.
Other hematology & oncology in York
- Daniel Efiom-EkahaYork$346K
- Chanh HuynhYork$115K
- Dan SotirescuYork$114K
- Salman FazalPittsburgh$2.3M
- Cyrus KhanPittsburgh$1.9M
- Usama GergisAllentown$1.2M
- Kit LuHarrisburg$810K
- Henry FungPhiladelphia$730K
- Alexander BarsoukPittsburgh$674K
- Abdalla SholiWilliamsport$576K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.